Among these pathways the one driven by FGF19, and its tyrosine kinase receptor FGFR4 and co-receptor β-klotho, is perhaps the best characterized in its functional interaction with the β-catenin system in HCC cells [32]. Here, FGFR4 is linked to hepatocellular carcinoma.